Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology
Crossref DOI link: https://doi.org/10.1038/srep20441
Published Online: 2016-02-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hart, Thomas
Dider, Shihab
Han, Weiwei
Xu, Hua
Zhao, Zhongming
Xie, Lei
Text and Data Mining valid from 2016-02-04
Version of Record valid from 2016-02-04
Article History
Received: 9 October 2015
Accepted: 4 January 2016
First Online: 4 February 2016
Competing interests
: The authors declare no competing financial interests.